These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 20865640

  • 21. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.
    Kopp A, Strobel S, Tortajada A, Rodríguez de Córdoba S, Sánchez-Corral P, Prohászka Z, López-Trascasa M, Józsi M.
    J Immunol; 2012 Aug 15; 189(4):1858-67. PubMed ID: 22786770
    [Abstract] [Full Text] [Related]

  • 22. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep 15; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

  • 23. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
    Józsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C.
    Blood; 2008 Feb 01; 111(3):1512-4. PubMed ID: 18006700
    [Abstract] [Full Text] [Related]

  • 24. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF, Skerka C.
    Curr Opin Rheumatol; 2006 Sep 01; 18(5):548-55. PubMed ID: 16896298
    [Abstract] [Full Text] [Related]

  • 25. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.
    Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Frémeaux-Bacchi V.
    J Am Soc Nephrol; 2005 Feb 01; 16(2):555-63. PubMed ID: 15590760
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group.
    Clin J Am Soc Nephrol; 2013 Mar 01; 8(3):407-15. PubMed ID: 23243267
    [Abstract] [Full Text] [Related]

  • 32. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome.
    Kwon T, Dragon-Durey MA, Macher MA, Baudouin V, Maisin A, Peuchmaur M, Fremeaux-Bacchi V, Loirat C.
    Nephrol Dial Transplant; 2008 Jun 01; 23(6):2088-90. PubMed ID: 18326881
    [No Abstract] [Full Text] [Related]

  • 33. Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
    Ferri M, Zotta F, Donadelli R, Dossier C, Duneton C, El-Sissy C, Fremeau-Bacchi V, Kwon T, Quadri L, Pasini A, Sellier-Leclerc AL, Vivarelli M, Hogan J.
    Pediatr Nephrol; 2024 Nov 01; 39(11):3263-3269. PubMed ID: 38632123
    [Abstract] [Full Text] [Related]

  • 34. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V, Bonucchi D, De Amicis S, Americo C, Ghiandai G, Cappelli G.
    Transplant Proc; 2010 May 01; 42(4):1352-4. PubMed ID: 20534299
    [Abstract] [Full Text] [Related]

  • 35. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P, Dickenmann M, Schifferli JA.
    Nephron Clin Pract; 2010 May 01; 114(4):c219-35. PubMed ID: 20090363
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.
    Boels MG, Lee DH, van den Berg BM, Dane MJ, van der Vlag J, Rabelink TJ.
    Eur J Intern Med; 2013 Sep 01; 24(6):503-9. PubMed ID: 23357408
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hemolytic uremic syndrome].
    Rota S, Cravedi P, Remuzzi G, Ruggenenti P.
    G Ital Nefrol; 2005 Sep 01; 22 Suppl 33():S57-64. PubMed ID: 16419008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.